UPEXI, INC.
UPXI evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for UPXI—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Financial data as of Mar 31, 2026.
Run UPEXI, INC. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available UPEXI, INC. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
24.5 months
OCF -$5M · Net income -$109M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Runway
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
53
Total value held
$15.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 6,765,204 | $6.7M |
| mmcap international inc. spc | 2,326,777 | $2.3M |
| susquehanna international group, llp | 1,260,528 | $1.2M |
| jane street group, llc | 908,995 | $896K |
| osaic holdings, inc. | 775,862 | $768K |
| blackrock, inc. | 681,308 | $671K |
| geode capital management, llc | 538,517 | $531K |
| citadel advisors llc | 418,800 | $413K |
| j. derek lewis & associates inc. | 249,000 | $351K |
| vanguard fiduciary trust co | 327,983 | $323K |
Showing top 10 of 53 institutional holders of UPEXI, INC.. Open the full 13F history after sign-in.
Short Interest
as of May 22, 2026- % of float
- 28.4%
- Days to cover
- 6.0
- Shares short
- 18,191,777
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
UPXI short interestGovernance
Frequently asked questions
Who is the CEO of UPEXI, INC.?
Mr. Allan J. Marshall is the chief executive officer of UPEXI, INC. (UPXI).
Where is UPEXI, INC. headquartered?
UPEXI, INC. (UPXI) is headquartered in Tampa, FL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.